1 active school or business cancellations.

×

Sign In

FDA approves JNJ’s combination therapy for patients with a type of lung cancer

By Thomson Reuters Mar 1, 2024 | 1:58 PM

(Reuters) – The FDA said on Friday it has approved Johnson & Johnson’s therapy in combination with other chemotherapies for the first-line treatment of a type of lung cancer.

(Reporting by Sriparna Roy in Bengaluru; Editing by Shailesh Kuber)

Comments

Leave a Reply Cancel reply

You must be logged in to post a comment.

Nolan Arenado Next Team Odds: Powerhouse favorites flip

Wausau City Council Approves Second Year of Lead Service Line Replacement Project

Commanders WR Noah Brown sustained internal injuries

Chiefs OT D.J. Humphries (hamstring) sits; Harrison Butker returns

Ehrisman Found Not Guilty by Mental Disease or Defect in Attempted Homicide Case

Wild owner on keeping Kirill Kaprizov: 'It's a priority'